Comparing Chemours (NYSE:CC) and Standard Lithium (OTCMKTS:SLI)

Chemours (NYSE:CCGet Rating) and Standard Lithium (OTCMKTS:SLIGet Rating) are both basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, analyst recommendations, earnings, valuation and profitability.

Insider and Institutional Ownership

71.9% of Chemours shares are owned by institutional investors. Comparatively, 19.7% of Standard Lithium shares are owned by institutional investors. 3.0% of Chemours shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Chemours and Standard Lithium’s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Chemours $6.35 billion 0.80 $608.00 million $5.61 6.01
Standard Lithium N/A N/A -$30.10 million ($0.20) -18.20

Chemours has higher revenue and earnings than Standard Lithium. Standard Lithium is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks.

Risk & Volatility

Chemours has a beta of 1.84, meaning that its stock price is 84% more volatile than the S&P 500. Comparatively, Standard Lithium has a beta of 2.35, meaning that its stock price is 135% more volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Chemours and Standard Lithium, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemours 1 8 2 0 2.09
Standard Lithium 0 0 0 0 N/A

Chemours currently has a consensus price target of $32.90, suggesting a potential downside of 2.43%. Given Chemours’ higher possible upside, equities research analysts plainly believe Chemours is more favorable than Standard Lithium.

Profitability

This table compares Chemours and Standard Lithium’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Chemours 12.91% 73.45% 11.42%
Standard Lithium N/A -25.32% -24.66%

Summary

Chemours beats Standard Lithium on 11 of the 12 factors compared between the two stocks.

About Chemours

(Get Rating)

The Chemours Co. is a holding company, which engages in the provision of performance chemicals. The firm delivers solutions, which include a range of industrial and chemical products for markets including coatings, plastics, refrigeration and air conditioning, transportation, semiconductor and consumer electronics, and general industrial. It operates through the following segments: Titanium Technologies, Thermal and Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment is involved in the manufacture of titanium dioxide pigment. The Thermal and Specialized Solutions segment offers refrigerants, propellants, blowing agents, and specialty solvents. The Advanced Performance Materials segment produces polymers and advanced materials that deliver attributes, including chemical inertness, thermal stability, low friction, weather and corrosion resistance, extreme temperature stability, and di-electric properties. The Chemical Solutions segment refers to the sale of chemicals used in industrial and consumer applications in the Americas. The company was founded on February 18, 2014, and is headquartered in Wilmington, DE.

About Standard Lithium

(Get Rating)

Standard Lithium Ltd. engages in the testing and proving of the commercial viability of lithium extraction. Its projects include Arkansas Lithium, Lithium Brine Processing, and California Lithium. The company was founded by Alvaro Anthony on August 14, 1998 and is headquartered in Vancouver, Canada.

Receive News & Ratings for Chemours Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours and related companies with MarketBeat.com's FREE daily email newsletter.